Company Filing History:
1 out of 27 
1 out of 3,539 
Years Active: 2024
Title: Innovator Sze Chun Winson Ho: Pioneering Advances in Cancer Treatment
Introduction: Sze Chun Winson Ho, based in Bethesda, MD, is an accomplished inventor with a significant contribution to the field of cancer treatment through innovative pharmaceutical methods. He holds one patent that showcases his expertise and commitment to advancing healthcare.
Latest Patents: Ho's notable patent is titled "Oxabicycloheptanes for modulation of immune response." This invention provides a method for treating individuals afflicted with cancer by administering an effective amount of a PP2A inhibitor, highlighting his dedication to developing effective treatment options for serious health conditions.
Career Highlights: Throughout his career, Sze Chun Winson Ho has worked with leading organizations, including Lixte Biotechnology, Inc. and the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. His efforts have greatly contributed to the progress of medical science and the fight against cancer.
Collaborations: Ho's work has involved collaboration with esteemed professionals, including colleagues such as John S Kovach and Zhengping Zhuang. These partnerships have facilitated the exchange of ideas and fostered innovation in his research endeavors.
Conclusion: Sze Chun Winson Ho stands out as a significant figure in the realm of cancer treatment innovations. His patent on PP2A inhibitors demonstrates his commitment to improving the lives of patients through advanced medical solutions. As research continues, his contributions will likely pave the way for further breakthroughs in the fight against cancer.